Category: China
-
Chinese ASI again targets European IP enforcement, prompting Dutch AASI backed by penalties of up to €100 million
Years after China’s 2020 ASI wave, a Chinese ASI has again targeted European IP enforcement, prompting a Dutch AASI backed by penalties of €1 million per day, capped at €100 million. Although the Dutch case concerns trademarks, the confrontation has significant implications for cross-border patent litigation.
-
CNIPA’s five-year plan spans pre-filing commercial assessments, AI-assisted inventions, possible SEP pilot, drug patent linkage disputes
To help bring inventions to market, China’s patent office will study how to assess their commercial prospects before filing. Its five-year plan also addresses how AI affects inventive step, a possible SEP examination pilot and closer coordination of patent validity challenges with disputes over generic drug entry.
-
TCL’s binding pledge in Delhi narrows its options for interim relief in Shenzhen against InterDigital’s Brazilian HEVC injunction
The Delhi High Court held TCL to its German counsel’s assurance that TCL would not interfere with InterDigital’s right to enforce its patents. The pledge leaves TCL little room to seek an antisuit injunction and could also constrain a request in Shenzhen for an interim license covering the sales enjoined in Brazil.
-
China’s proposed patent screening for SME support reflects broader shift from volume to quality and commercial value
China’s proposed patent screening for SME support builds on tighter eligibility rules and a broader drive to curb abnormal filings, improve patent quality, and encourage commercial use.
-
How to bring licensing deals over the line, according to Xiaomi’s patent licensing director
In an interview with ip fray, licensing director Cheng Yu discusses how he personally characterizes the conduct of good-faith licensors seeking royalties, weighs whether to sign a deal or risk litigation, and explains the advantages of mediation and more open communication with the global IP community.
-
China’s top court clarifies when claim amendments can end drug patent-linkage cases: how U.S. Hatch-Waxman actions differ
Narrowing claims can save a drug patent but end its pending linkage case in China. A newly posted Supreme People’s Court case explains when that can happen, while U.S. Hatch-Waxman cases illustrate different requirements for litigating amended claims before launch.
-
China, Hong Kong-based defendants now account for roughly one-third of new UPC infringement and PI cases
Chinese and Hong Kong-based defendants now account for about a third of new UPC infringement and PI cases and face above-average injunction rates, as the UPC stays few cases pending EPO oppositions.
-
China links patent rulings to customs enforcement: solar disputes could disrupt global deliveries before goods leave port
A patent fight in China could disrupt overseas deliveries before goods leave a port. With solar singled out for stronger protection, closer links between administrative rulings and customs enforcement may raise the stakes of licensing negotiations across global supply chains.
-
OPPO wins fast-charging injunctions in China as its 5G and VVC counteroffensive challenges ASUS’s licensing campaign
OPPO has obtained another first-instance fast-charging injunction against ASUS in China, bringing its wins on that front to two alongside its 5G and VVC patent counteroffensive. The dispute now spans Europe, China, and India.
-
OPPO, Nidec have taken Qi Wireless Power patent pool license, Via announces during AI licensing-focused Summit
During its annual Bridge Summit in San Francisco today, which will largely focus on opportunities and strategies in AI patent licensing, Via Licensing Alliance announced Japan’s Nidec Mobility Corporation and China’s OPPO – already a licensor – have both taken a license in Via’s Qi Wireless Power patent pool.